# Nintedanib

NDC: 43598-147
Generic name: Nintedanib
Labeler / Manufacturer: Dr. Reddy's Laboratories Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20260402

FDA application: ANDA219283

## Active ingredients

- NINTEDANIB ESYLATE: 150 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"43598-147"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=43598-147
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=88f8600d-0974-51ca-6f8e-28c48a379e08